Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Medigene AG
Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
April 25, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene to Present at Upcoming Scientific Conferences
April 17, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024
April 08, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG Secures European Patent for its iM-TCR Technology
April 04, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
March 28, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
March 19, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG to report full year 2023 financial results on March 28, 2024
March 18, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Protein with a Poster Presentation at AACR 2024 Annual Meeting
March 06, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo
March 04, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentiated TCR-T Therapies
February 29, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene to Present at Upcoming Conferences
February 19, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR-T Therapy Program in Solid Tumors
February 12, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cash Runway
November 21, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene amends 2023 financial guidance
November 21, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capability of its proprietary E2E Platform to generate multiple enhanced TCR-T therapies against mKRAS G12V A*11
November 04, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene Reports Financial Results and Corporate Update for Q3 2023
October 26, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene presents first pre-clinical data of optimal affinity TCR targeting mKRAS G12V combined with a PD1-41BB costimulatory switch protein showing enhanced and sustained tumor killing
October 23, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene to present new pre-clinical data for pipeline TCR-T therapies at the ESMO Congress 2023
October 16, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene AG Secures European Patent for its PD1-41BB Costimulatory Switch Protein
September 27, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene AG Announces Lead Selection for MDG2011 Representing the First TCR-T Therapy of its KRAS Library
September 18, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene AG to present at the Baader Investment Conference 2023
September 11, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene AG to present at the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene presents rationale for combining its 3S TCRs with enhancement tools as an approach to improve clinical outcomes
August 30, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene Expands Intellectual Property Rights for its Costimulatory Switch Proteins to Additional Immune Cell Types
August 23, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene AG to present at the 8th CAR-TCR Summit in Boston
August 22, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene AG Reports Second Quarter and Six Months 2023 Financial Results and Provides Corporate Update
August 17, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene to participate in the H.C. Wainwright Immune Cell Engager Virtual Conference
August 16, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene AG to report Second Quarter and Six Months 2023 Financial Results and Corporate Update on August 17, 2023
August 10, 2023
From
Medigene AG
Via
GlobeNewswire
Medigene Presents Enhanced Tumor Cell Killing Effects upon Addition of PD1-41BB Switch Receptor to TCR-T Therapies
June 22, 2023
From
Medigene AG
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.